Christopher Famulare
Memorial Sloan Kettering Cancer Center(US)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Myeloproliferative Neoplasms: Diagnosis and Treatment, Cancer Genomics and Diagnostics, Chronic Myeloid Leukemia Treatments, Histone Deacetylase Inhibitors Research
Most-Cited Works
- → The N6-methyladenosine (m6A)-forming enzyme METTL3 controls myeloid differentiation of normal hematopoietic and leukemia cells(2017)1,300 cited
- → Single-cell mutation analysis of clonal evolution in myeloid malignancies(2020)512 cited
- → Acquired resistance to IDH inhibition through trans or cis dimer-interface mutations(2018)278 cited
- → Isoform Switching as a Mechanism of Acquired Resistance to Mutant Isocitrate Dehydrogenase Inhibition(2018)207 cited
- → Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML(2021)181 cited
- → Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia(2019)145 cited
- → Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure(2020)129 cited
- → Plasmacytoid dendritic cell expansion defines a distinct subset of RUNX1 -mutated acute myeloid leukemia(2020)113 cited
- → Functional screen of MSI2 interactors identifies an essential role for SYNCRIP in myeloid leukemia stem cells(2017)106 cited
- → Overcoming adaptive therapy resistance in AML by targeting immune response pathways(2019)87 cited